172 related articles for article (PubMed ID: 18766374)
21. BCG vaccine effectiveness in preventing tuberculosis and its interaction with human immunodeficiency virus infection.
Arbeláez MP; Nelson KE; Muñoz A
Int J Epidemiol; 2000 Dec; 29(6):1085-91. PubMed ID: 11101552
[TBL] [Abstract][Full Text] [Related]
22. Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial.
Nissen TN; Birk NM; Kjærgaard J; Thøstesen LM; Pihl GT; Hoffmann T; Jeppesen DL; Kofoed PE; Greisen G; Benn CS; Aaby P; Pryds O; Stensballe LG
Vaccine; 2016 May; 34(22):2477-82. PubMed ID: 27060379
[TBL] [Abstract][Full Text] [Related]
23. Surgical complications of bacille Calmette-Guérin (BCG) infection in HIV-infected children: time for a change in policy.
Karpelowsky JS; Alexander AG; Peek SD; Millar AJ; Rode H
S Afr Med J; 2008 Oct; 98(10):801-4. PubMed ID: 19115758
[TBL] [Abstract][Full Text] [Related]
24. Use of BCG in high prevalence areas for HIV.
Felten MK; Leichsenring M
Trop Med Parasitol; 1995 Jun; 46(2):69-71. PubMed ID: 8525287
[TBL] [Abstract][Full Text] [Related]
25. Danish bacille Calmette-Guérin vaccine-induced disease in human immunodeficiency virus-infected children.
Hesseling AC; Schaaf HS; Hanekom WA; Beyers N; Cotton MF; Gie RP; Marais BJ; van Helden P; Warren RM
Clin Infect Dis; 2003 Nov; 37(9):1226-33. PubMed ID: 14557968
[TBL] [Abstract][Full Text] [Related]
26. BCG vaccination in India and tuberculosis in children: newer facets.
Udani PM
Indian J Pediatr; 1994; 61(5):451-62. PubMed ID: 7744445
[TBL] [Abstract][Full Text] [Related]
27. Use of purified protein derivative to assess the risk of infection in children in close contact with adults with tuberculosis in a population with high Calmette-Guérin bacillus coverage.
Almeida LM; Barbieri MA; Da Paixão AC; Cuevas LE
Pediatr Infect Dis J; 2001 Nov; 20(11):1061-5. PubMed ID: 11734712
[TBL] [Abstract][Full Text] [Related]
28. Immune reconstitution syndrome due to bacillus Calmette-Guérin after initiation of antiretroviral therapy in children with HIV infection.
Puthanakit T; Oberdorfer P; Punjaisee S; Wannarit P; Sirisanthana T; Sirisanthana V
Clin Infect Dis; 2005 Oct; 41(7):1049-52. PubMed ID: 16142674
[TBL] [Abstract][Full Text] [Related]
29. BCG scarring and improved child survival: a combined analysis of studies of BCG scarring.
Benn CS; Roth A; Garly ML; Fisker AB; Schaltz-Buchholzer F; Timmermann A; Berendsen M; Aaby P
J Intern Med; 2020 Dec; 288(6):614-624. PubMed ID: 32301189
[TBL] [Abstract][Full Text] [Related]
30. Bacillus Calmette-Guérin immunization in infants born to HIV-1-seropositive mothers.
Lallemant-Le Coeur S; Lallemant M; Cheynier D; Nzingoula S; Drucker J; Larouze B
AIDS; 1991 Feb; 5(2):195-9. PubMed ID: 2031692
[TBL] [Abstract][Full Text] [Related]
31. Levels of vaccination coverage among HIV-exposed children in China: a retrospective study.
Shen R; Wang AL; Pan XP; Qiao YP; Wang Q; Wang XY; Qu SL; Zhang T
Infect Dis Poverty; 2021 Mar; 10(1):18. PubMed ID: 33648599
[TBL] [Abstract][Full Text] [Related]
32. Tuberculosis and HIV co-infections in Jamaican children.
Geoghagen M; Farr JA; Hambleton I; Pierre R; Christie CD
West Indian Med J; 2004 Oct; 53(5):339-45. PubMed ID: 15675501
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for human immunodeficiency virus infection in Ethiopian children with tuberculosis.
Palme IB; Gudetta B; Degefu H; Bruchfeld J; Muhe L; Giesecke J
Pediatr Infect Dis J; 2001 Nov; 20(11):1066-72. PubMed ID: 11734713
[TBL] [Abstract][Full Text] [Related]
34. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
Fu H; Lin HH; Hallett TB; Arinaminpathy N
Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
[TBL] [Abstract][Full Text] [Related]
35. Chapter 5: Health staff roles and responsibilities, recording and reporting and BCG vaccination.
;
Int J Tuberc Lung Dis; 2007 Feb; 11(2):134-7. PubMed ID: 17263281
[TBL] [Abstract][Full Text] [Related]
36. Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1.
Ryder RW; Oxtoby MJ; Mvula M; Batter V; Baende E; Nsa W; Davachi F; Hassig S; Onorato I; Deforest A
J Pediatr; 1993 May; 122(5 Pt 1):697-702. PubMed ID: 8496745
[TBL] [Abstract][Full Text] [Related]
37. Interactions of the human immunodeficiency virus and tuberculosis and the implications for BCG vaccination.
Quinn TC
Rev Infect Dis; 1989; 11 Suppl 2():S379-84. PubMed ID: 2652254
[TBL] [Abstract][Full Text] [Related]
38. Severe BCG immune reconstitution inflammatory syndrome lymphadenitis successfully managed with pre-antiretroviral counseling and a non-surgical approach: a case report.
Machava P; Joaquim W; Borrell J; Richardson S; Cassia U; Sidat M; Maieca A; Massitela C; Quelhas Y; Mucuila C; Elias B; da Rocha M; Schaaf HS; Buck WC
AIDS Res Ther; 2024 Apr; 21(1):25. PubMed ID: 38678293
[TBL] [Abstract][Full Text] [Related]
39. Disseminated BCG disease and the full contraindication to BCG vaccination for children exposed to and/or infected by HIV.
Fernandes RC; Medina-Acosta E
Int J Tuberc Lung Dis; 2009 Sep; 13(9):1188-9; author reply 1189-90. PubMed ID: 19723415
[No Abstract] [Full Text] [Related]
40. Disseminated Bacillus Calmette-Guerin infection after BCG vaccination.
Rezai MS; Khotaei G; Mamishi S; Kheirkhah M; Parvaneh N
J Trop Pediatr; 2008 Dec; 54(6):413-6. PubMed ID: 18593737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
